Cargando…
HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation
Autores principales: | Reusing, Sarah B., Manser, Angela R., Groeneveld-Krentz, Stefanie, Rebmann, Vera, Horn, Peter A., Meisel, Roland, Karawajew, Leonid, Borkhardt, Arndt, Uhrberg, Markus, Babor, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263342/ https://www.ncbi.nlm.nih.gov/pubmed/33658648 http://dx.doi.org/10.1038/s41409-021-01231-y |
Ejemplares similares
-
Characterization of leukemia-specific NK cell subsets against acute lymphoblastic leukemia in children
por: Babor, Florian, et al.
Publicado: (2014) -
CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL
por: Reusing, Sarah B., et al.
Publicado: (2021) -
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL
por: Reusing, Sarah B., et al.
Publicado: (2021) -
Hematopoietic Stem Cell Transplantation in an Infant with Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome
por: Gössling, Katharina L., et al.
Publicado: (2017) -
The role of KIR genes and ligands in leukemia surveillance
por: Babor, Florian, et al.
Publicado: (2013)